Cargando…
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects
BACKGROUND: Despite multiple antidepressant options, major depressive disorder (MDD) still faces high non-response rates, eventually requiring anticonvulsant augmentation strategies too. The aim of this study was to explore such a potential role for zonisamide. METHODS: A total of 40 MDD outpatients...
Autores principales: | Fornaro, Michele, Martino, Matteo, Dalmasso, Bruna, Colicchio, Salvatore, Benvenuti, Marzia, Rocchi, Giulio, Escelsior, Andrea, Perugi, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184102/ https://www.ncbi.nlm.nih.gov/pubmed/21929762 http://dx.doi.org/10.1186/1744-859X-10-23 |
Ejemplares similares
-
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
por: Fornaro, Michele, et al.
Publicado: (2011) -
A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010) -
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
por: Martino, Matteo, et al.
Publicado: (2012) -
The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007) -
Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2012)